{"name":"ConvaTec","slug":"convatec","ticker":"CTEC","exchange":"LSE","domain":"convatecgroup.com","description":"Convatec Group plc, trading as Convatec, is a medical products and technologies company based in London, England, offering products and services in the areas of advanced wound care, ostomy care, continence care and infusion care. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.","hq":"Reading, United Kingdom","founded":1978,"employees":"10910","ceo":"Karim Bitar","sector":"Ostomy / Wound / Continence / Infusion Care","stockPrice":224.8,"stockChange":10.4,"stockChangePercent":4.85,"marketCap":"$4.4B","metrics":{"revenue":2439000064,"revenueGrowth":7.1,"grossMargin":56.3,"rdSpend":0,"netIncome":175000000,"cash":68000000,"dividendYield":2.51,"peRatio":32.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"AQUACEL patent cliff ($100M at risk)","drug":"AQUACEL","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"CONVATEC Ostomy Pouch patent cliff ($50M at risk)","drug":"CONVATEC Ostomy Pouch","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"ConvaTec Reports Fourth Quarter and Full Year 2023 Results","summary":"ConvaTec reported fourth quarter and full year 2023 results, with revenue of $1.1 billion and adjusted EBITDA of $245 million.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"ConvaTec Announces Agreement to Sell its Advanced Wound Care Business","summary":"ConvaTec announced an agreement to sell its advanced wound care business to a private equity firm.","drugName":"","sentiment":"neutral"},{"date":"2023-06-15","type":"regulatory","headline":"ConvaTec Receives FDA Clearance for its Ostomy Care Product","summary":"ConvaTec received FDA clearance for its new ostomy care product, which is designed to improve patient comfort and convenience.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPVVBTQ0ROUlBUQlpHZVlpenBYUU5nMzlaX0F3c1Vmc2pJdGR1QkE4VTB0VURFaHlMazNBSnM0UmZwTVZXa1JheWRhNlJzb2kwTDl6Y0JGVm0xN1JBX0dnT0VWQmZXdU0yVVo5TVZQQ0tiOGFWN0ZqNEhFcm9xMVFCMENpM2pMUHJ2eVRFQVRkalFTdUs1SDZFV2F4cVo4ODNCczdIM25kMF80YWJWY2c5TGJ2VVJFSWlaN08wVTJFbw?oc=5","date":"2026-02-24","type":"pipeline","source":"proactiveinvestors.com","summary":"ConvaTec climbs after upgrading medium-term outlook - proactiveinvestors.com","headline":"ConvaTec climbs after upgrading medium-term outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOcktCTEFnelNTYUNzb1djUDJoWThTb1l4N1FnNUNpQzQ0bkVzU0c5UmIzMUhwY1NsTFQ2cmM1V2RPaEVDSUNpNGV0MUVWYXZnbm1DSDJrMC03dncxUlRqUnZjWVZHUENrWE5HNG1hOUlhQmRCeFlBWUJiemktX1JHUGdKSXNYbW1FNVRsVzlVX1dtVE1qMWNVc1NLUHBKQi1hMEFDSm1HM1RnWE1CTVNWOQ?oc=5","date":"2026-01-05","type":"pipeline","source":"Kalkine Media","summary":"Convatec Group (LSE:CTEC) Shares Track FTSE 100 Index In Early Trade - Kalkine Media","headline":"Convatec Group (LSE:CTEC) Shares Track FTSE 100 Index In Early Trade","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxONEZjTTVRZVBIQVpHNWNqNmh6YmRVQW94ZVNCeXoyZk1DZ1ozRjRRUTI4bUpJSUFGOFRGTU1ITjd2bkYycUtKNlNQcDk2TGs0QUI3dXNyTnFhOV9OR3JVWU9HdEJpU1c2WVFoUDVKVk93LWRRU0RtVEJzN2w1ZjlyNlRGcFRDbXVYRkVKMlV5bW5Jb0xpRnF6ci1fZ2ljcENRdHZuMThRNlpocXpGanpHekpkeXFEa0pacG4xdU1zcVVwd0pWNmhz?oc=5","date":"2025-11-18","type":"pipeline","source":"reuters.com","summary":"Novo Holdings exits UK's Convatec after discounted share sale, bookrunner says - reuters.com","headline":"Novo Holdings exits UK's Convatec after discounted share sale, bookrunner says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOa0dLUW5hbXdZS3R1RDlBN3JubTBSY2REc3VmeU80MEJxQ0Nucm5tTjlzc0cwclRJZGJlYmpQZUJLeWc4VjdkbFRLRVo0VE1rQWZBMlZIel81Q2pNYUhVRXBZdjdvdzJrcGpBbXFXVTVBX0tQdHEwOFlPNGlOdnNkUzhlV0JxTGM4?oc=5","date":"2025-10-01","type":"pipeline","source":"Investors' Chronicle","summary":"Companies roundup: Pharma stocks & Taylor Wimpey - Investors' Chronicle","headline":"Companies roundup: Pharma stocks & Taylor Wimpey - Investors' Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOR3hiWlNZWVdrcGlDQzFQMzlpTTZVaVlpMmlSdDJ0aXV0TF9SYjdIc2tySzQwNC1MOFJwalBfYi1aQkRxNlFRaHFXR3h1Njc1MHVOVXpsRHZ4NHF0YXRlUGxVWHVsTnVzNnBsbjVaZ2l1Wk5XcUVoU1Q1X0gwZ0ZPdUExSjN5UEtKQ1lDX0JtWjd0cmZ5NXBPc0tTNzU4MU4xNVhHQVFodmhqOEdCZDYwQXZhN2djXzNFYTlSd0NRZXF1QQ?oc=5","date":"2025-08-20","type":"deal","source":"Proactive Investors","summary":"Convatec shares jump 7 % after unveiling $300m buyback - Proactive Investors","headline":"Convatec shares jump 7 % after unveiling $300m buyback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOTFBYQW1hRjExcFp1UG94YVZoeGhhTkJUbTVpZEJMc1p4Rk5TUnRRQW5rOEtKQVVYSU1HeV9LNkFuQ080M3Uxa0NWVnJYQlZ1RmlxdENoeHRnZ0lPdHlhYnVSSnhCa0VVYVR5OF9EMEJWTUpZYmpsMEwtdFpQNWlsd3puMVE4UGFMWGI2Qlp2M2lObTF2NU9JVldOb3Fhc193TkZ4WjdRODJTLXNDQjhEMXg3Ulo?oc=5","date":"2025-08-04","type":"pipeline","source":"Sharecast.com","summary":"Convatec CEO to take medical leave of absence - Sharecast.com","headline":"Convatec CEO to take medical leave of absence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOQzdpa1NBcXctWmVQeFA1YVhERm5icXJUVGVDNU45UXhENWt0MGRxbC1ERDlSTkJEY0pCeDEzWjZEbVZpMkNEZnQ5blYyTDdpTHpwYl9jZGtMY0Q5MXctLUREVENiMl9UQWx2eEg5LXNsMTFZUmpRUlN0bVl6aEpvb29NbFNKUy1DcF91NG1HUXlSeDhyaGJMd3VzM1BBM0h2MWJkenYza0pKTzBwT29V?oc=5","date":"2025-04-25","type":"pipeline","source":"The Pharma Letter","summary":"Convatec to launch nitric oxide product as analysts highlight resilience - The Pharma Letter","headline":"Convatec to launch nitric oxide product as analysts highlight resilience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNRXNjNVFKTTZhd1FyNHhYMGttS0lKaWZvbTF4b3VDaXZvZUZJSWd6N1NtX1hHeENEbzhZbG5BRWREXzl4bEZlNDBlY1ZyeDZORTNNNXRqdUtzWk9vWXlLZ1Z5TS1qVzlpMGp5d2FuQ2FxX0V6ZVNyczJMNlpLbzF5WmRHLUxFc1RNZ0p1UmdlZGYzekJ3aFdIa0poMnZjalNhMnd6RUhBTU42c1BUSko0RFNvamZ4LTdqb3VXSGNsVlZ3eV90Sk16SzdRRmpvTHZBZWZjdkd3?oc=5","date":"2025-04-10","type":"pipeline","source":"Proactive Investors","summary":"ConvaTec stands out in a sea of difficulties for European med-tech - Proactive Investors","headline":"ConvaTec stands out in a sea of difficulties for European med-tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeG5GeUlsZTVQZm5MTlU3YUtzazVhSEVIMDE3eXBiVjJxcHpfZXlkQzBOZFlmdjV4ZjgtZmU0d2tiMGVoRjJFY1VWTUdBZmNGcnZBTExoSXN6aVlRTnVZNlRFT01EVC1TMGI5X3lLcHlId2xmQ3NHajZiM1FEOUlabDBEd3pZcDlY?oc=5","date":"2024-12-05","type":"pipeline","source":"Investors' Chronicle","summary":"A FTSE hidden gem that deserves to be recognised - Investors' Chronicle","headline":"A FTSE hidden gem that deserves to be recognised - Investors' Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBVX1hwdDBJZ1VCY1dBU005SkJDYnE3TjJPLVBtNVJTUEc2TEFNTjVFUDFzMlRxTnpJNEhmWDhBZmZfZ3AyUHhtczl4cjk5U05sc0ZwY3dOWm1nVHlWVTFyZ25R?oc=5","date":"2024-05-11","type":"pipeline","source":"MarketBeat","summary":"ConvaTec Group (CTEC) Stock Forecast and Price Target 2026 $CTEC - MarketBeat","headline":"ConvaTec Group (CTEC) Stock Forecast and Price Target 2026 $CTEC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9za0U1YW1QcVBUTGJ1cFNxQ2tnRzkzVHVRb3hDVmI2Z09hdUFaekJ4UC1pd1FRQm85cFYyWjE1SnhuZ181QXhVSDFNMmpVY29nanY1dXRqZjZfN1hsdnM4YS1OZHktdWc4YXJlMXNnaVY4T2hBV25CcTA1Rlo?oc=5","date":"2020-04-28","type":"pipeline","source":"MarketBeat","summary":"Top ConvaTec Group (CTEC) Competitors 2026 - MarketBeat","headline":"Top ConvaTec Group (CTEC) Competitors 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNY05EQlJsQXBXak9XUjFPUzJzNS14X3F3UEt2Q2pidVZjWTQ5c2RfSEI4MFRhdkNzcEowdS16WlJhRkNMY1VNTUJxMVh6T0tIQXVsaDBCNWhhZVZqaXRMampZNU5XN2dDejBvYmVXTHNGUmpfdXdDSXF3ZThDbVhsSVA5M0FNU3lQTHJBMg?oc=5","date":"2019-03-26","type":"pipeline","source":"MassDevice","summary":"ConvaTec taps Bitar as CEO | Personnel Moves – March 26, 2019 - MassDevice","headline":"ConvaTec taps Bitar as CEO | Personnel Moves – March 26, 2019","sentiment":"neutral"}],"patents":[{"drugName":"AQUACEL","drugSlug":"hydrofiber-dressing","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000},{"drugName":"CONVATEC Ostomy Pouch","drugSlug":"ostomy-pouch","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"EU","annualRevenue":50000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["3M","Coloplast","B. Braun"],"therapeuticFocus":["Ostomy Care","Wound Care","Continence Care"],"financials":null,"yahoo":{"currentPrice":224.8,"previousClose":214.4,"fiftyTwoWeekHigh":311.2,"fiftyTwoWeekLow":209.4,"fiftyTwoWeekRange":"209.4 - 311.2","fiftyDayAverage":230.86,"twoHundredDayAverage":236.95,"beta":0.84,"enterpriseValue":5640350720,"forwardPE":13.3,"priceToBook":384.82,"priceToSales":1.8,"enterpriseToRevenue":2.31,"enterpriseToEbitda":9.61,"pegRatio":1.47,"ebitda":587000000,"ebitdaMargin":24.1,"freeCashflow":241500000,"operatingCashflow":470000000,"totalDebt":1518000000,"debtToEquity":100,"currentRatio":1.53,"returnOnAssets":7,"returnOnEquity":10.9,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":18,"targetMeanPrice":306.25,"targetHighPrice":369.26,"targetLowPrice":255.06,"dividendRate":0.05,"payoutRatio":0.79,"fiveYearAvgDividendYield":2.07,"exDividendDate":1776297600,"insiderHeldPercent":0.2,"institutionHeldPercent":79.7,"sharesOutstanding":1954454579,"floatShares":1937587636,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":0.07,"epsForward":0.17,"revenuePerShare":1.21,"bookValue":0.58,"officers":[{"age":61,"name":"Mr. Jonathan Peter Mason","title":"CEO & Director"},{"age":50,"name":"Ms. Fiona Victoria Ryder","title":"Group Financial Controller, CFO & Director"},{"age":null,"name":"Mr. Walter  Morse","title":"Interim Chief Quality & Operations Officer"},{"age":null,"name":"Dr. Divakar  Ramakrishnan Ph.D.","title":"Executive VP, Chief Technology Officer and Head of Research & Development"},{"age":45,"name":"Mr. James Edward Spencer Kerton","title":"EVP, General Counsel & Company Secretary"},{"age":null,"name":"Ms. Emma  Rose","title":"EVP & Chief People Officer"},{"age":64,"name":"Ms. Kjersti  Grimsrud Biotechnology, M.Sc.","title":"President & COO of Infusion Care"},{"age":null,"name":"Mr. David  Shepherd","title":"Chief Commercial Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.convatecgroup.com","phone":""}}